# Leuprolide acetate treatment and myoma arterial size.

> PubMed lists PMID 7651647 in Obstetrics and gynecology as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1995-09 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-7651647-leuprolide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-7651647-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-7651647-leuprolide-v1.json
- Content SHA-256: `7cfe26188caea74575f36ce1408b0c99cc2a10e2d1d791f8c92f10f694242247`

## Claims and source pins

### Headline

Leuprolide acetate treatment and myoma arterial size. ([`pubmed-observation-pmid-7651647-2013-11-21-5bca8092c85f`](#source-pubmed-observation-pmid-7651647-2013-11-21-5bca8092c85f))

### Summary

PubMed lists PMID 7651647 in Obstetrics and gynecology as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1995-09 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-7651647-2013-11-21-5bca8092c85f`](#source-pubmed-observation-pmid-7651647-2013-11-21-5bca8092c85f))

### Paragraph 1

PubMed lists PMID 7651647 in Obstetrics and gynecology as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1995-09 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-7651647-2013-11-21-5bca8092c85f`](#source-pubmed-observation-pmid-7651647-2013-11-21-5bca8092c85f))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-7651647-2013-11-21-5bca8092c85f`](#source-pubmed-observation-pmid-7651647-2013-11-21-5bca8092c85f))

## Sources

<a id="source-pubmed-observation-pmid-7651647-2013-11-21-5bca8092c85f"></a>
- **Leuprolide acetate treatment and myoma arterial size. · retained source version 1:2013-11-21:current:5bca8092c85f4bc5e85f14314de747b6c38779b7d8fd5b85f63c8c46b1a61842** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/7651647/) (`pubmed-observation-pmid-7651647-2013-11-21-5bca8092c85f`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Leuprolide acetate treatment and myoma arterial size." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-7651647-leuprolide-v1.json SHA-256: 7cfe26188caea74575f36ce1408b0c99cc2a10e2d1d791f8c92f10f694242247.